A genotype-first approach reveals the molecular basis of pyrin inflammasome activation

View at publisher
Authors: Naoya Iwata, Yoshihiko Kuchitsu, Atsushi Hijikata, Hirofumi Shibata, Masahiko Nishitani‐Isa, Mariko Aoki, Kazushi Izawa, Hiroyuki Yoshitomi, Junko Takita, Hideki Ueno, Tomohiko Taguchi, Takahiro Yasumi
+1 more Yoshitaka Honda
Cited by: 4
References: 61

Abstract

Mutations in the MEFV gene, which encodes pyrin, are associated with a spectrum of inflammatory conditions called pyrin-associated autoinflammatory diseases (PAADs). Of the 400 MEFV variants listed in the Infevers database, most are classified as variants of uncertain significance. Thus, genetic diagnosis of PAADs remains challenging, and the molecular mechanisms underlying pyrin activation remain poorly understood. Here, we used a cell-based pyroptosis assay to stratify 265 missense MEFV variants and identified previously uncharacterized pathogenic variants. We then characterized the interaction between the pyrin B30.2 domain and CDC42, a key regulator of pyrin intracellular trafficking and activation. We found that classical familial Mediterranean fever (FMF)–related variants bind tightly to CDC42 to induce pyrin hyperactivation, whereas certain non-FMF variants induce pyrin hyperactivation independently of CDC42, indicating involvement of multiple pathways in pyrin activation. Our approach provides a proof of concept for a genotype-first approach, which may advance our understanding of complex human diseases.

Fields of Study & Subjects

Inflammasome and immune disorders interferon and immune responses Osteomyelitis and Bone Disorders Research

Publication details

Journal / source
Science Immunology
Publisher
American Association for the Advancement of Science (AAAS)
Volume
11
Issue
122
Pages
eaea0705–eaea0705
Publication date
7 August 2026
Language
EN